Search Results - "DARKOW, Theodore"

Refine Results
  1. 1

    Adherence to a Fixed-Dose Combination of Rosiglitazone/Glimepiride in Subjects Switching from Monotherapy or Dual Therapy with a Thiazolidinedione and/or a Sulfonylurea by Thayer, Sarah, Arondekar, Bhakti, Harley, Carolyn, Darkow, Theodore E

    Published in The Annals of pharmacotherapy (01-05-2010)
    “…BACKGROUND: In 2005, a fixed-dose combination therapy (FDCT) of rosiglitazone maleate and glimepiride became available for treatment of type 2 diabetes…”
    Get full text
    Journal Article
  2. 2

    A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes by Borah, Bijan J., PhD, Darkow, Theodore, PharmD, Bouchard, Jonathan, MS, Aagren, Mark, MSc, Forma, Felicia, BSc, Alemayehu, Berhanu, DrPH

    Published in Clinical therapeutics (01-03-2009)
    “…Abstract Objectives: The goal of this study was to compare daily insulin use, glycemic control, and health care costs in insulin-naive patients with type 2…”
    Get full text
    Journal Article
  3. 3

    A decade of antimicrobial susceptibilities at the University of Kentucky Hospital by Rapp, RP, Ribes, JA, Overman, SB, Darkow, TE, Evans, ME

    Published in The Annals of pharmacotherapy (01-04-2002)
    “…OBJECTIVE: To determine the antimicrobial susceptibility rates for key antimicrobial agents and selective bacterial pathogens in the decade of the 1990s…”
    Get full text
    Journal Article
  4. 4

    Treatment interruptions and non-adherence with imatinib and associated healthcare costs : A retrospective analysis among managed care patients with chronic myelogenous leukaemia by DARKOW, Theodore, HENK, Henry J, THOMAS, Simu K, WEIWEI FENG, BAIADI, Jean-Francois, GOLDBERG, George A, HATFIELD, Alan, CORTES, Jorge

    Published in PharmacoEconomics (01-01-2007)
    “…Identify treatment interruptions and non-adherence with imatinib; examine the clinical and patient characteristics related to treatment interruptions and…”
    Get full text
    Journal Article
  5. 5

    Adherence and persistence among chronic myeloid leukemia patients during second-line tyrosine kinase inhibitor treatment by Trivedi, Digisha, Landsman-Blumberg, Pamela, Darkow, Theodore, Smith, David, McMorrow, Donna, Mullins, C Daniel

    “…Chronic myeloid leukemia (CML) treatment is lifelong, and while it is important for patients to remain adherent to treatment, there are conflicting findings…”
    Get full text
    Journal Article
  6. 6

    Adherence and persistence to second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia by Trivedi, Digisha, Amin, Shahla, Zhu, Ling, Joo, Sam, Kawabata, Hugh, Darkow, Theodore, Hebden, Tony

    Published in Journal of clinical oncology (20-05-2012)
    “…Abstract only e17009 Background: Some studies have demonstrated the correlation between adherence and persistence to therapy and the effectiveness of that…”
    Get full text
    Journal Article
  7. 7

    Incidence and costs of cervical intraepithelial neoplasia in a US commercially insured population by Henk, Henry J, Insinga, Ralph P, Singhal, Puneet K, Darkow, Theodore

    Published in Journal of lower genital tract disease (01-01-2010)
    “…This study aimed to estimate incidence, cost per episode of care, and US population burden of cervical intraepithelial neoplasia (CIN). For women continuously…”
    Get full text
    Journal Article
  8. 8

    Coverage and use of cancer therapies in the treatment of chronic myeloid leukemia by Darkow, Theodore, Maclean, Ross, Joyce, Geoffrey F, Goldman, Dana, Lakdawalla, Darius N

    Published in The American journal of managed care (01-11-2012)
    “…This study was designed to assess the effect of tyrosine kinase inhibitor (TKI) use on nonpharmaceutical medical spending for patients with chronic myeloid…”
    Get full text
    Journal Article
  9. 9

    Costs Associated with the Management of Overactive Bladder and Related Comorbidities by Darkow, Theodore, Fontes, Christina L., Williamson, Todd E.

    Published in Pharmacotherapy (01-04-2005)
    “…Study Objective. To evaluate the clinical and economic impact of overactive bladder (OAB) on the management of related comorbidities in a managed care…”
    Get full text
    Journal Article
  10. 10

    Prevalence and cost of HIV-associated weight loss in a managed care population by Siddiqui, Javeed, Phillips, Amy L., Freedland, Eric S., Sklar, Ami R., Darkow, Theodore, Harley, Carolyn R.

    Published in Current medical research and opinion (01-05-2009)
    “…ABSTRACT Objective: To estimate the prevalence of HIV-associated weight loss among HIV patients in a US managed care population, and compare demographic and…”
    Get full text
    Journal Article
  11. 11

    Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system by Darkow, Theodore, Vanderplas, Ann M., Lew, Kim H., Kim, Jennifer, Hauch, Ole

    Published in Current medical research and opinion (01-10-2005)
    “…ABSTRACT Objective: To examine warfarin utilization and clinical effectiveness among patients with nonvalvular atrial fibrillation within usual clinical care…”
    Get full text
    Journal Article
  12. 12

    Health Care Costs Among Individuals With Chronic Obstructive Pulmonary Disease Within Several Large, Multi-State Employers by Darkow, Theodore, Chastek, Benjamin J., Shah, Hemal, Phillips, Amy L.

    “…Objective: To estimate chronic obstructive pulmonary disease (COPD)-attributable medical resource utilization and health care costs among employed individuals…”
    Get full text
    Journal Article
  13. 13

    Patient and physician perception of the infusion process of the biologic agents abatacept, infliximab, and rituximab for the treatment of rheumatoid arthritis by YAZICI, Y, MCMORRIS, B. J, DARKOW, T, ROSENBLATT, L. C

    Published in Clinical and experimental rheumatology (01-11-2009)
    “…To assess the process related to each infusible biologic used in rheumatoid arthritis (RA) with regard to patient and physician engagement in the infusion…”
    Get full text
    Journal Article
  14. 14

    A Retrospective Analysis of Disability and Its Related Costs Among Employees With Chronic Obstructive Pulmonary Disease by Darkow, Theodore, Kadlubek, Pamela J., Shah, Hemal, Phillips, Amy L., Marton, Jenő P.

    “…Objective: The objective of this study was to examine the frequency and cost of disability among actively employed individuals with chronic obstructive…”
    Get full text
    Journal Article
  15. 15

    A Retrospective Analysis of Disability and Its Related Costs Among Employees With Chronic Obstructive Disease by Darkow, Theodore, Kadlubek, Pamela J, Shah, Hemal, Phillips, Amy L, Marton, Jeno P

    “…The objective of this study was to examine the frequency and cost of disability among actively employed individuals with chronic obstructive pulmonary disease…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Impact of Antiemetic Selection on Postoperative Nausea and Vomiting and Patient Satisfaction by Darkow, Theodore, Gora-Harper, Mary Lea, Goulson, Daniel T., Record, Kenneth E.

    Published in Pharmacotherapy (01-05-2001)
    “…Study Objective. To determine the impact of antiemetic selection on postoperative nausea and vomiting (PONV) and patient satisfaction after ambulatory surgery…”
    Get full text
    Journal Article
  18. 18

    Medical costs after initiation of drug treatment for overactive bladder: effects of selection bias on cost estimates by Nitz, Nicole M, Jumadilova, Zhanna, Darkow, Theodore, Frytak, Jennifer R, Bavendam, Tamara

    Published in The American journal of managed care (01-07-2005)
    “…To compare posttreatment medical costs for patients with overactive bladder (OAB) initiating treatment with oxybutynin chloride immediate release (oxybutynin…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Opioid analgesics versus ketorolac in spine and joint procedures: impact on healthcare resources by Gora-Harper, ML, Record, KE, Darkow, T, Tibbs, PA

    Published in The Annals of pharmacotherapy (01-11-2001)
    “…BACKGROUND: Ketorolac's efficacy as a postoperative analgesic has been shown to be comparable to that of narcotic analgesics, but with significantly fewer…”
    Get full text
    Journal Article